- NEWS
- Correction 03 April 2018
Pioneering Alzheimer’s study in Colombia zeroes in on enigmatic protein
Elenith is enrolled in a study of people whose families carry a genetic mutation for early-onset Alzheimer's, but she doesn't know whether she will develop the disease. "It has haunted me all of my life but I want to be prepared if possible," she says. Credit: Greg Kendall-Ball/Nature
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 555, 567-568 (2018)
doi: https://doi.org/10.1038/d41586-018-03848-4
Travel for this story was paid for by the Pulitzer Center on Crisis Reporting in Washington DC.
Updates & Corrections
-
Correction 03 April 2018: This story originally misstated the radioactive marker that will be used in the tau scans. It is GTP1.
References
Quiroz, Y. T. et al. JAMA Neurol. http://dx.doi.org/10.1001/jamaneurol.2017.4907 (2018).
Reiman, E. et al. Lancet Neurol. 11, 1048–1056 (2012).
Ossenkoppele, R. et al. Brain 139, 1551–1567 (2016).
